Description

FILITRA 10 MG

Indications

FILITRA 10 MG is primarily indicated for the treatment of erectile dysfunction (ED) in adult males. It is designed to improve the ability to achieve and maintain an erection sufficient for satisfactory sexual performance. This medication is often prescribed for patients who have not responded adequately to other treatments for ED. FILITRA may also be used in specific cases of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical worsening.

Mechanism of Action

The active ingredient in FILITRA 10 MG is Vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor. Its mechanism of action involves the inhibition of the PDE5 enzyme, which leads to an increase in the levels of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. This increase in cGMP results in smooth muscle relaxation and enhanced blood flow to the penile tissue during sexual stimulation, facilitating an erection. The efficacy of FILITRA is contingent upon sexual arousal, as it does not induce an erection in the absence of sexual stimulation.

Pharmacological Properties

FILITRA 10 MG is rapidly absorbed following oral administration, with peak plasma concentrations typically occurring within 30 to 120 minutes. The bioavailability of Vardenafil is approximately 15%, and its effects can last for up to 5 hours, although the duration may vary among individuals. The drug is metabolized primarily in the liver via the cytochrome P450 enzyme system, particularly CYP3A4. The elimination half-life of Vardenafil is about 4 to 5 hours, and it is excreted mainly in the feces and urine.

Contraindications

FILITRA 10 MG is contraindicated in patients who are hypersensitive to Vardenafil or any of the excipients in the formulation. It should not be used in conjunction with nitrates or nitric oxide donors, as this combination can lead to significant hypotension. Additionally, patients with severe cardiovascular disorders, such as unstable angina, recent myocardial infarction, or severe heart failure, should avoid using this medication. It is also contraindicated in individuals with severe hepatic impairment or those undergoing dialysis.

Side Effects

Common side effects associated with FILITRA 10 MG include headache, flushing, nasal congestion, dyspepsia, and dizziness. These effects are usually mild to moderate in intensity and tend to resolve spontaneously. Serious adverse effects, although rare, may include priapism (prolonged erection), sudden hearing loss, and vision changes. Patients should be advised to seek immediate medical attention if they experience any severe or persistent side effects.

Dosage and Administration

The recommended starting dose of FILITRA 10 MG is one tablet taken orally approximately 30 to 60 minutes before anticipated sexual activity. Depending on individual efficacy and tolerability, the dose may be adjusted to 5 MG or increased to a maximum of 20 MG. It is important to note that FILITRA should not be taken more than once a day. Patients are advised to avoid consuming high-fat meals prior to taking the medication, as this may delay its onset of action.

Interactions

FILITRA 10 MG may interact with various medications, leading to altered therapeutic effects or increased risk of side effects. Notable drug interactions include those with other PDE5 inhibitors, nitrates, and alpha-blockers, which can enhance the hypotensive effects of Vardenafil. Additionally, medications that affect the CYP3A4 enzyme, such as certain antifungals (e.g., ketoconazole), antibiotics (e.g., erythromycin), and HIV protease inhibitors, may increase plasma concentrations of Vardenafil, necessitating careful monitoring and possible dose adjustments. Patients should inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Before prescribing FILITRA 10 MG, healthcare providers should conduct a thorough medical history and physical examination. Caution is advised in patients with a history of cardiovascular disease, as sexual activity itself poses a degree of risk. Additionally, patients with anatomical deformities of the penis or conditions that may predispose them to priapism should be monitored closely. It is also essential to assess for any underlying psychological factors contributing to erectile dysfunction, as these may require concurrent treatment.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of FILITRA 10 MG in treating erectile dysfunction. In randomized, double-blind, placebo-controlled trials, patients reported significant improvements in erectile function, as measured by the International Index of Erectile Function (IIEF) and other validated questionnaires. The studies indicated that Vardenafil was effective across a range of ED severities and in various patient populations, including those with comorbid conditions such as diabetes and hypertension. Long-term studies suggest that FILITRA maintains its efficacy over extended periods of use, with a favorable safety profile.

Conclusion

FILITRA 10 MG is an effective treatment option for men experiencing erectile dysfunction. By inhibiting the PDE5 enzyme, it facilitates improved blood flow to the penis, enhancing the ability to achieve and maintain an erection. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. A thorough assessment by a healthcare provider is crucial to ensure safe and appropriate use of this medication. With proper guidance, FILITRA can significantly improve the quality of life for men suffering from ED.